1. Introduction {#sec1}
===============

Malaria is an infection with high morbidity and mortality burden all over world which is endemic in African region. Data from the World Health Organization malaria report 2019 revealed the occurrence of an estimate of 228 million cases and 405 000 deaths from the infection worldwide in 2018. Nigeria has 25% and 19% of the global cases and deaths respectively, follow by Democratic Republic of Congo with 11% each of the global cases and deaths. The most vulnerable are children below 5 years of age responsible for 67% (585 000) of the global malaria deaths in 2018 ([@bib27]). *Plasmodium falciparum* is the most deadly of the five species of malaria parasite known to infect human ([@bib8]; [@bib27]).

Quinoline present in several antimalarial drugs such as Chloroquine, Amodiaquine, Mefloquine, Primaquine, Ferroquine, etc. has been considered as the most important moiety that impact antimalarial action out of many heterocycle pharmacophores known for treatment of malaria ([@bib15]; [@bib11]). Chloroquine has been the most effective antimalaria for decades, but the wide spread of its resistance led to the development of Artemisinin-based Combination Therapy (ACTs), the WHO recommended drug for treatment of uncomplicated malaria ([@bib6]). ACTs are drug combinations containing artemisinin derivatives and other antimalarials such as quinoline compounds. Resistance to ACTs was reported in some part of the world which jeopardized their future effectiveness hence, the need for promising antimalaria that will meet the challenge of eradicating the disease ([@bib7]; [@bib1]). Alternative to ACTs are hybrid compounds which have advantage of hitting two or more molecular targets ([@bib17]). Earlier this year, Rania and coworkers reported the synthesis of 1,3-dioxoisoindoline-4-aminoquinolines ([Figure 1](#fig1){ref-type="fig"}) as potent and noncytotoxic hybrid compounds having excellent antiplasmodial activities against W2 strain of *P. falciparum* ([@bib20]).Figure 11,3-dioxoisoindoline-4-aminoquinolines.Figure 1

Conventional drug discovery methods are expensive and time-consuming, hence, the need for more effective methods in terms of time and resources ([@bib13]). Discovery of novel drug candidates require efficient and vigorous methods that can screen chemical databases against molecules with known biological activities ([@bib23]). QSAR and molecular docking studies have been successfully deployed in the discovery and design of many drugs for their time and cost effectiveness ([@bib22]). This work aim at applying these techniques to reveal the connection between chemical structures of 1,3-dioxoisoindoline-4-aminoquinolines and their antiplasmodial activities so as to come up with a model that could be used to design highly potent antimalaria.

2. Materials and method {#sec2}
=======================

2.1. Data collection {#sec2.1}
--------------------

36 compounds of 1,3-dioxoisoindoline-4-aminoquinolines ([Figure 1](#fig1){ref-type="fig"}) and their antiplasmodial activities against W2 strain of *Plasmodium falciparum* were obtained from the work of Rania and co-workers ([@bib20]) and used in this research. The antiplasmodial activities of the compounds were gotten as IC~50~ (nM) and converted to pIC~50~ {pIC~50~ = -logIC~50~ (M)} for the purpose of this work. The compounds with their respective activities were presented in [Table 1](#tbl1){ref-type="table"}.Table 1Compounds of [Figure 1](#fig1){ref-type="fig"} with their antiplasmodial activities.Table 1CompoundsRmNIC~50~(nM)1H125.652H143.663H163.354H180.245H220.306H240.417H260.298H280.159H320.2810H340.8411H361.5712H380.5813F121.9914F141.0515F161.4916F220.3617F240.2218F260.6619Morpholinyl123.2120Morpholinyl141.2821Morpholinyl161.7822Morpholinyl220.1323Morpholinyl240.2224Morpholinyl260.6425Diethylamino121.1426Diethylamino141.1727diethylamino161.2228diethylamino220.09729diethylamino240.2630diethylamino260.53312-(piperazin-1-yl)ethan-1-ol121.04322-(piperazin-1-yl)ethan-1-ol140.86332-(piperazin-1-yl)ethan-1-ol160.46342-(piperazin-1-yl)ethan-1-ol220.28352-(piperazin-1-yl)ethan-1-ol240.14362-(piperazin-1-yl)ethan-1-ol260.18

2.2. Geometric optimization {#sec2.2}
---------------------------

The 2D structures of the molecules shown in [Table 1](#tbl1){ref-type="table"} were drawn using Chemdraw version 12.0.2 software ([@bib16]), converted to 3D and optimized using Spartan 14 Version 1.1.4 software (using B3LYP functional and 6-31G basis set) ([@bib4]) (see Supplementary file Table 1 for 2D and 3D structures).

2.3. Molecular descriptors calculation {#sec2.3}
--------------------------------------

A total of 1875 molecular descriptors of the optimized molecules of 1,3-dioxoisoindoline-4-aminoquinolines derivatives were computed with PaDEL-Descriptor software version 2.20 ([@bib28]).

2.4. Normalization and data pretreatment {#sec2.4}
----------------------------------------

Using [Eq. (1)](#fd1){ref-type="disp-formula"}, the computed descriptors were normalized so that each variable will have equal opportunity in construction of the model ([@bib21]).$$X = \frac{X_{i} - X_{min}}{X_{max} - X_{min}}$$where X is the normalized descriptors, X~i~ is the descriptor\'s value for each molecule, X~min~ and X~max~ are minimum and maximum values for each descriptor. Data Pretreatment software of Drug Theoretical and Cheminformatics Laboratory (DTC Lab) was used to eliminate redundancy in the normalized data.

2.5. Data Division {#sec2.5}
------------------

Kennard-Stone\'s algorithm was employed to divide the data into training set and test set ([@bib14]) using Data Division software of DTC Lab. Training set (70%) was used in building the model while test set (30%) in validating the model.

2.6. Model generation {#sec2.6}
---------------------

Regression analysis of the training set was carried out using Genetic Function Approximation (GFA) technique in Material Studio software to generate the model. Activities in pIC~50~ were taken as the dependent variable and the descriptors independent variables.

2.7. Internal validation of the model generated {#sec2.7}
-----------------------------------------------

The model generated was assessed using Friedman formula ([@bib9]) defined as;$$LOF = \frac{SEE}{\left( {1 - \frac{c + dp}{M}} \right)^{2}}$$

LOF is the Friedman\'s Lack of fit which is a measure of fitness of a model, SEE is the standard error of estimation, p is the total number of descriptors in the model, d is the user-defined smoothing parameter, c is the number of terms in the model and M is the number of compounds in the training set.

SEE is defined as;$$SEE = \sqrt{\frac{\left( Y_{\exp - Y_{prd}} \right)^{2}}{N - P - 1}}$$which is the same as the standard deviation of the model and its value has to be low for a model to be good.

Correlation coefficient, R^2^ of a built model is another parameter considered and the closer it is to 1.0, the better the model built. R^2^ is expressed as;$$R^{2} = 1 - \sqrt{\frac{\sum^{}\left( {Y_{exp} - Y_{prd}} \right)^{2}}{\sum^{}\left( {Y_{exp} - Y_{mtrn}} \right)^{2}}}$$where Y~prd~, Y~exp~ and Y~mtrn~ are the predicted, experimental and mean experimental activities in the training set, respectively.

The stability of a model is not reliable on the value of R^2^ as it is directly proportional to the number of descriptors in the model. Thus, for a reliable and stable model, R^2^ is adjusted according to the expression:$$R_{adj}^{2} = \frac{\left( {n - 1} \right)\left( {R^{2} - p} \right)}{n - p - 1}$$where p is the number of descriptors in the model and n number of compounds used in training set.

The cross-validation coefficient, Q^2^~cv~ expressed as:$$Q_{cv}^{2} = 1 - \frac{\sum^{}\left( {Y_{prd} - Y_{exp}} \right)^{2}}{\sum^{}\left( {Y_{exp} - Y_{mtrn}} \right)^{2}}$$where Y~prd~, Y~exp~ and Y~mtrn~ are the predicted, experimental and average experimental activity in the training set, respectively.

2.8. External validation of the model generated {#sec2.8}
-----------------------------------------------

Test set was used in validating the generated model externally by assessing the value of R^2^~pred~ expressed as;$$R_{pred}^{2} = 1 - \frac{\sum^{}\left( {Y_{prd} - Y_{exp}} \right)^{2}}{\sum^{}\left( {Y_{exp} - Y_{mtrn}} \right)^{2}}$$where Y~prd~ and Y~exp~ are respectively the predicted and experimental activities of the test set and Y~mtrn~ the mean experimental activity of the training set. The closer the value is to 1.0, the better the model generated ([@bib24]).

2.9. Y-Randomization test {#sec2.9}
-------------------------

Random Multi-Linear regression models are generated (using training set) in Y-randomization test whose R^2^ and Q^2^ values have to be low for the QSAR model to be robust ([@bib24]). Coefficient of determination, cR^2^~p~, whose value has to be greater than 0.5 for passing this test is also calculated in the Y-randomization test and is expressed as;$$cR_{p}^{2} = Rx\left( {R^{2} - R_{r}^{2}} \right)^{2}$$where R is the correlation coefficient for Y-randomization and R^2^~r~ is the average 'R' of the random models.

2.10. Applicability domain of the generated model {#sec2.10}
-------------------------------------------------

Leverage (h~i~) method was used in describing the applicability domain of the QSAR models ([@bib26]) and for a chemical compound is expressed as;$$h_{i} = X_{i}\left( {X^{T}X} \right)^{- 1}X_{I}^{T}$$where X~i~ is training compounds matrix of i. X is the n x k descriptor matrix of the training set compound and X^T^ is the transpose matrix of X used to generate the model. The warning leverage, h∗ is the maximum value for X and is expressed as;$$h^{\ast} = \frac{3\left( p + 1 \right)}{n}$$where n is the number of training compounds and p is the number of descriptors in the model.

2.11. Descriptors analyses {#sec2.11}
--------------------------

Correlation analysis was carried out to check the presence of correlation among the descriptors in the built model. This was further evaluated by computing the variance inflation factor (VIF) for each descriptor using the equation below (see supplementary file Table 2 for the values of descriptors used in the model):$$\text{VIF}_{\text{i}} = \frac{1}{1 - R_{ij}^{2}}$$

VIF~i~ is the variance inflation factor for a given descriptor i in the model R^2^~ij~ is the correlation coefficient of the multiple regression between the descriptor i and the remaining j descriptors in the model ([@bib5]).

The relative significance and influence of every descriptor in the model was estimated by its mean effect (MF) value. The MF~j~ for a given descriptor j in a model is given as;$$\text{MF}_{\text{j}} = \frac{\beta_{j}\sum_{i = 1}^{i = n}d_{ij}}{\sum_{j}^{m}\beta_{j}\sum_{i}^{n}d_{ij}}$$where bj is the coefficient of descriptor j in the model, d~ij~ is the value of the descriptor j in the descriptor matrix for each molecule in the training set, m is the number of descriptors that appear in the model, and n is the number of molecule that made up the training set ([@bib10]).

2.12. Docking study {#sec2.12}
-------------------

*Plasmodium falciparum* lactate dehydrogenase (*Pf*LDH) enzyme is regarded as a potential molecular target for antimalarials because of the parasite\'s reliance on glycolysis to produce energy ([@bib18]). Therefore, molecular docking study was conducted between *Pf*LDH and 1,3-dioxoisoindoline-4-aminoquinolines to investigate their interaction. Crystal structure of *Pf*LDH was obtained from protein data bank (PDB ID: [1CET](pdb:1CET){#intref0010}). Ten compounds with best activities were prepared as the ligands for this study. *Pf*LDH was prepared as the receptor with the aid of Discovery Studio software. The prepared receptor and ligands were docked using Autodock Vina in Pyrx software ([@bib25]). Discovery Studio Visualizer was use to analyze the results.

3. Result and discussion {#sec3}
========================

Four QSAR models were built using GFA in material studio software to study how the biological activities of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium relate with their chemical structures. One of the QSAR models generated was selected for its statistical significance and reported herein as follow:$$\begin{array}{ll}
\text{pIC}_{50} & {= - 0.013998081\ \ \text{∗}\ \ \mathbf{A}\mathbf{T}\mathbf{S}\mathbf{C}5\mathbf{i}} \\
 & {- 13.821502296\ \ \text{∗}\ \ \mathbf{G}\mathbf{A}\mathbf{T}\mathbf{S}8\mathbf{p}} \\
 & {+ 0.328734328\ \ \text{∗}\ \ \mathbf{m}\mathbf{i}\mathbf{n}\mathbf{H}\mathbf{B}\mathbf{i}\mathbf{n}\mathbf{t}3} \\
 & {+ 0.138391673\ \ \text{∗}\ \ \mathbf{m}\mathbf{i}\mathbf{n}\mathbf{H}\mathbf{B}\mathbf{i}\mathbf{n}\mathbf{t}5} \\
 & {+ 3.211439246\ \ \text{∗}\ \ \mathbf{M}\mathbf{L}\mathbf{F}\mathbf{E}\mathbf{R}\_\mathbf{A}} \\
 & {- 2.474169940\ \ \text{∗}\ \ \mathbf{t}\mathbf{o}\mathbf{p}\mathbf{o}\mathbf{S}\mathbf{h}\mathbf{a}\mathbf{p}\mathbf{e}} \\
 & {+ 20.552944618} \\
\end{array}$$

[Table 2](#tbl2){ref-type="table"} presents the validation parameters of the model which passed the thresholds required for a QSAR model to be accepted ([@bib26]; [@bib23]).Table 2Validation parameters for the selected model.Table 2S/NParameterValue1Friedman LOF0.0832R^2^~train~0.9463Adjusted *R*-squared0.9284Cross-validated *R*-squared (*Q*^2^~cv~)0.8885Significant regressionYes6Significance-of-regression F-value48.267Critical SOR F-value (95%)2.6728Replicate points09Computed experimental error010Lack-of-fit points1811Min expt. error for nonsignificant LOF (95%)0.10312R^2^~test~0.702

The model contained 2D Autocorrelation descriptors ATSC5i and GATS8p which described how the considered properties (first ionization potential and atomic polarizabilities) are distributed along the topological structures of the molecules. ATSC5i is defined as centered Broto-Moreau autocorrelation of lag 5 weighted by first ionization potential and it present in the model related the first ionization potential of pairs atoms that are separated by five bonds (lag 5) with the antiplasmodial activities of 1,3-dioxoisoindoline-4-aminoquinolines, while GATS8p is defined as Geary autocorrelation of lag 8 weighted by atomic polarizabilities and it present in the model associated the presence of polarizable pairs of atoms eight bonds apart on the antiplasmodial activities the compounds. The model also contained 2D atom type electro-topological state descriptors minHBint3 and minHBint5 which are defined as Minimum E-State descriptors of strength for potential Hydrogen Bonds of path length 3 (minHBint3) and of path length 5 (minHBint5). These descriptors indicated the importance of hydrogen bonds of path length 3 and 5 ([@bib3]). Other descriptors in the model were Overall or summation solute hydrogen bond acidity, MLFER_A which is related with molecular linear free energy relations ([@bib19]) and Petitjean topological shape index, topoShape.

[Table 3](#tbl3){ref-type="table"} shows the residual values between the experimental and predicted activities of 1,3-dioxoisoindoline-4-aminoquinolines as potent *Plasmodium falciparum* inhibitors. The low residual values were indicative of the high predictability of the model.Table 3Experimental and predicted pIC~50~ of 1,3-dioxoisoindoline-4-aminoquinolines with their residuals.Table 3CompoundsExperimental pIC~50~Predicted pIC~50~Residual15.2485.331-0.0832[a](#tbl3fna){ref-type="table-fn"}5.4375.523-0.08735.4755.523-0.0484[a](#tbl3fna){ref-type="table-fn"}6.626.3550.264456.5236.716-0.1936[a](#tbl3fna){ref-type="table-fn"}6.3876.777-0.3976.5386.4340.103586.8246.914-0.0996.5536.5180.035210[a](#tbl3fna){ref-type="table-fn"}6.0765.9090.1669115.8045.7460.058112[a](#tbl3fna){ref-type="table-fn"}6.2376.2360.0007135.7015.6550.0459145.9795.80.179155.8276.006-0.179166.4446.447-0.00317[a](#tbl3fna){ref-type="table-fn"}6.6586.5260.1317186.186.204-0.024195.4935.57-0.07720[a](#tbl3fna){ref-type="table-fn"}5.8935.530.36321[a](#tbl3fna){ref-type="table-fn"}5.755.796-0.046226.8866.7930.0932236.6586.6340.0238246.1946.342-0.148255.9435.998-0.05526[a](#tbl3fna){ref-type="table-fn"}5.9325.9120.019427[a](#tbl3fna){ref-type="table-fn"}5.9146.147-0.233287.0136.7260.287296.5856.5660.0193306.2766.286-0.011315.9835.8670.116132[a](#tbl3fna){ref-type="table-fn"}6.0665.8580.2075336.3376.2020.1356346.5536.644-0.091356.8546.942-0.088366.7456.751-0.006[^1]

[Table 4](#tbl4){ref-type="table"} presents the result of statistical analysis of the descriptors. The low values of the inter-correlation between any pair of descriptors as shown by the Pearson\'s correlation matrix suggest no significant inter-correlation among the descriptors used in building the model. This was confirmed by the low value of the Variance Inflation Factor which was less than 10 for every descriptor. Hence, the descriptors used in building the model were good. The mean effects of the descriptors gave the relative influences of the descriptors on the antiplasmodial activities of the compounds where the signs and the magnitudes indicated the directions and extent of the influences respectively. The MF values suggested that the descriptors ATSC5i, minHBint3, minHBint5 and MLFER_A decrease the antimalarial activities of 1,3-dioxoisoindoline-4-aminoquinolines with increase in their values while the descriptors GATS8p and topoShape increase the antimalarial activities of 1,3-dioxoisoindoline-4-aminoquinolines with increase in their values. The magnitude of the MF values shows that the descriptor GATS8p has greatest influence on the antiplasmodial activities of the compounds and should be highly considered when designing more potent 1,3-dioxoisoindoline-4-aminoquinolines. The descriptor ATSC5i had the least influence on the antiplasmodial activities of the compounds as shown by the magnitude of its MF.Table 4Pearson\'s correlation, Variance Inflation Factor (VIF) and Mean Effect (MF) of descriptors used in the selected model.Table 4DescriptorInter-correlationVIFMFATSC5iGATS8pminHBint3minHBint5MLFER_AtopoShapeATSC5i11.391-0.005GATS8p-0.118112.9940.983minHBint3-0.34220.335011.500-0.010minHBint5-0.40240.60210.333015.148-0.020MLFER_A0.13750.14200.1317-0.505312.704-0.110topoShape-0.0275-0.04510.2254-0.24680.246111.2210.166

The reliability, robustness and stability of the built QSAR model were confirmed by Y- Randomization test. This was true for the low R^2^ and Q^2^ values for several trials in the result presented in [Table 5](#tbl5){ref-type="table"}. The cR^2^p value which was greater than 0.5 also shows the model is good and not gotten by chance.Table 5Y-Randomization test result.Table 5ModelRR^2^Q^2^Original0.97260.94590.8883Random 10.41720.1741-0.7131Random 20.40800.1665-0.6273Random 30.69150.47820.0379Random 40.46690.2180-0.4743Random 50.60250.3631-0.2769Random 60.36530.1335-0.6688Random 70.48350.2338-0.6283Random 80.52670.2774-0.4792Random 90.26200.0686-0.8088Random 100.64300.4135-0.3519Random Models ParametersAverage r:0.4867Average r2:0.2526Average Q2:-0.4990cRp2:0.8189

The linearity of the plot of predicted activities against experimental activities of the compounds ([Figure 2a](#fig1){ref-type="fig"}) shows the strength of the model in predicting antiplasmodial activities of the 1,3-dioxoisoindoline-4-aminoquinolines. The dispersal of standardized residuals of both training and test set on both sides of zero ([Figure 2b](#fig1){ref-type="fig"}) suggested no systematic error in the generated model ([@bib12]).

The Williams plot presented by [Figure 3](#fig2){ref-type="fig"} shows no outliers in the compounds but three influential compounds because their leverages were greater than the warning leverage (*h∗* = 0.84) which might arose from their structural feature. All the compounds were within the applicability domain except the influential compounds which were all from test set (compound 4, 10 and 32). These compounds should not be considered when designing novel 1,3-dioxoisoindoline-4-aminoquinolines.Figure 2(a) Plot of predicted activities against experimental activities (b) Plot of Standardized residuals against experimental activities of the compounds.Figure 2

The result of the molecular docking study conducted between *Plasmodium falciparum* lactate dehydrogenase, *Pf*LDH (receptor) and ten 1,3-dioxoisoindoline-4-aminoquinolines with highest activities (ligands) is presented in Table 3 of the supplementary file. All the docked ligands interacted strongly with the active sites of the receptor with binding affinity ranging from -6.7 to -9.2 kcal/mol. They all exhibited significant hydrogen bonding and hydrophobic interaction with the amino acids of the protein. Figures [4](#fig3){ref-type="fig"}and [5](#fig4){ref-type="fig"} presented respectively the 3D and 2D 22-*pf*LDH interactions which had the best binding affinity (-9.2 kcal/mol). Five conventional hydrogen bond were formed between one of the C=O of the 1,3-dioxoisoindoline moiety and residue MET30, NH of the quinoline moiety and residue GLU122 and TYR85, C=O of the amide linker and residue GLY99 and NH of the amino group and residue ASP53. Two Carbon hydrogen bonds type were formed between two carbons of the morpholinyl substituent on the 1,3-dioxoisoindoline moiety and C=O of PRO246 and ASN140 of the target. The ligand also formed Hydrophobic interactions with the receptor via Pi-Sigma type with ILE54 and ILE119, Alkyl-Alkyl type with PRO246 and ILE119 and Pi-Alkyl type with PHE100 and ILE31 of the target. Unfavorable donor-donor interaction was also observed between the H of the amino group of the ligand H of the ILE54 of the receptor. The docked compounds have better binding affinity and interactions than chloroquine (a well known inhibitor of *pf*LDH).Figure 3Plot of the standardized residuals against the leverages (Williams plot).Figure 3Figure 43D interaction between Ligand 22 and *pf*LDH.Figure 4Figure 52D interaction between Ligand 22 and *pf*LDH.Figure 5

4. Conclusion {#sec4}
=============

QSAR and molecular docking techniques were successfully applied on 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodial in order to produce a model that relates the chemical structures of the molecules and their antiplasmodial activities. A predictable, reliable and robust model was generated using Genetic Function Approximation (GFA) technique in Material Studio software. The model has internal and external validation R^2^ values of 0.9459 and 0.701544 respectively. The model revealed that the antiplasmodial activities of 1,3-dioxoisoindoline-4-aminoquinolines is influence by ATSC5i, GATS8p, minHBint3, minHBint5, MLFER_A and topoShape descriptors with greatest and least effect from GATS8p and ATSC5i respectively. The docking study revealed the important of some strategic point on the structural features of the molecules in inhibiting *Plasmodium falciparum* lactate dehydrogenase (*Pf*LDH). This information could be used together with the built model to design novel 1,3-dioxoisoindoline-4-aminoquinolines inhibitors of *Pf*LDH with higher antiplasmodial activities.
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[^1]: Test set.
